Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibodies in Oncology Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Murine Antibodies
1.2.3 Chimeric and Humanised Antibodies
1.2.4 Fully Humanized Antibodies
1.2.5 Others
1.3 Market by Application
1.3.1 Global Antibodies in Oncology Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Academic Institutes
1.3.4 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibodies in Oncology Market Perspective (2018-2033)
2.2 Antibodies in Oncology Growth Trends by Region
2.2.1 Global Antibodies in Oncology Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Antibodies in Oncology Historic Market Size by Region (2018-2023)
2.2.3 Antibodies in Oncology Forecasted Market Size by Region (2024-2033)
2.3 Antibodies in Oncology Market Dynamics
2.3.1 Antibodies in Oncology Industry Trends
2.3.2 Antibodies in Oncology Market Drivers
2.3.3 Antibodies in Oncology Market Challenges
2.3.4 Antibodies in Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibodies in Oncology Players by Revenue
3.1.1 Global Top Antibodies in Oncology Players by Revenue (2018-2023)
3.1.2 Global Antibodies in Oncology Revenue Market Share by Players (2018-2023)
3.2 Global Antibodies in Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antibodies in Oncology Revenue
3.4 Global Antibodies in Oncology Market Concentration Ratio
3.4.1 Global Antibodies in Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibodies in Oncology Revenue in 2022
3.5 Antibodies in Oncology Key Players Head office and Area Served
3.6 Key Players Antibodies in Oncology Product Solution and Service
3.7 Date of Enter into Antibodies in Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibodies in Oncology Breakdown Data by Type
4.1 Global Antibodies in Oncology Historic Market Size by Type (2018-2023)
4.2 Global Antibodies in Oncology Forecasted Market Size by Type (2024-2033)
5 Antibodies in Oncology Breakdown Data by Application
5.1 Global Antibodies in Oncology Historic Market Size by Application (2018-2023)
5.2 Global Antibodies in Oncology Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Antibodies in Oncology Market Size (2018-2033)
6.2 North America Antibodies in Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Antibodies in Oncology Market Size by Country (2018-2023)
6.4 North America Antibodies in Oncology Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibodies in Oncology Market Size (2018-2033)
7.2 Europe Antibodies in Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Antibodies in Oncology Market Size by Country (2018-2023)
7.4 Europe Antibodies in Oncology Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibodies in Oncology Market Size (2018-2033)
8.2 Asia-Pacific Antibodies in Oncology Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Antibodies in Oncology Market Size by Region (2018-2023)
8.4 Asia-Pacific Antibodies in Oncology Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibodies in Oncology Market Size (2018-2033)
9.2 Latin America Antibodies in Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Antibodies in Oncology Market Size by Country (2018-2023)
9.4 Latin America Antibodies in Oncology Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibodies in Oncology Market Size (2018-2033)
10.2 Middle East & Africa Antibodies in Oncology Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Antibodies in Oncology Market Size by Country (2018-2023)
10.4 Middle East & Africa Antibodies in Oncology Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis International AG
11.1.1 Novartis International AG Company Detail
11.1.2 Novartis International AG Business Overview
11.1.3 Novartis International AG Antibodies in Oncology Introduction
11.1.4 Novartis International AG Revenue in Antibodies in Oncology Business (2018-2023)
11.1.5 Novartis International AG Recent Development
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Company Detail
11.2.2 GlaxoSmithKline plc Business Overview
11.2.3 GlaxoSmithKline plc Antibodies in Oncology Introduction
11.2.4 GlaxoSmithKline plc Revenue in Antibodies in Oncology Business (2018-2023)
11.2.5 GlaxoSmithKline plc Recent Development
11.3 Biogen Idec Inc.
11.3.1 Biogen Idec Inc. Company Detail
11.3.2 Biogen Idec Inc. Business Overview
11.3.3 Biogen Idec Inc. Antibodies in Oncology Introduction
11.3.4 Biogen Idec Inc. Revenue in Antibodies in Oncology Business (2018-2023)
11.3.5 Biogen Idec Inc. Recent Development
11.4 Bristol Myers Squibb Co.
11.4.1 Bristol Myers Squibb Co. Company Detail
11.4.2 Bristol Myers Squibb Co. Business Overview
11.4.3 Bristol Myers Squibb Co. Antibodies in Oncology Introduction
11.4.4 Bristol Myers Squibb Co. Revenue in Antibodies in Oncology Business (2018-2023)
11.4.5 Bristol Myers Squibb Co. Recent Development
11.5 AstraZeneca plc.
11.5.1 AstraZeneca plc. Company Detail
11.5.2 AstraZeneca plc. Business Overview
11.5.3 AstraZeneca plc. Antibodies in Oncology Introduction
11.5.4 AstraZeneca plc. Revenue in Antibodies in Oncology Business (2018-2023)
11.5.5 AstraZeneca plc. Recent Development
11.6 Celltrion
11.6.1 Celltrion Company Detail
11.6.2 Celltrion Business Overview
11.6.3 Celltrion Antibodies in Oncology Introduction
11.6.4 Celltrion Revenue in Antibodies in Oncology Business (2018-2023)
11.6.5 Celltrion Recent Development
11.7 3SBIO
11.7.1 3SBIO Company Detail
11.7.2 3SBIO Business Overview
11.7.3 3SBIO Antibodies in Oncology Introduction
11.7.4 3SBIO Revenue in Antibodies in Oncology Business (2018-2023)
11.7.5 3SBIO Recent Development
11.8 Celgen Biopharma
11.8.1 Celgen Biopharma Company Detail
11.8.2 Celgen Biopharma Business Overview
11.8.3 Celgen Biopharma Antibodies in Oncology Introduction
11.8.4 Celgen Biopharma Revenue in Antibodies in Oncology Business (2018-2023)
11.8.5 Celgen Biopharma Recent Development
11.9 Dr Reddy’s
11.9.1 Dr Reddy’s Company Detail
11.9.2 Dr Reddy’s Business Overview
11.9.3 Dr Reddy’s Antibodies in Oncology Introduction
11.9.4 Dr Reddy’s Revenue in Antibodies in Oncology Business (2018-2023)
11.9.5 Dr Reddy’s Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Antibodies in Oncology Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Murine Antibodies
Table 3. Key Players of Chimeric and Humanised Antibodies
Table 4. Key Players of Fully Humanized Antibodies
Table 5. Key Players of Others
Table 6. Global Antibodies in Oncology Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Antibodies in Oncology Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Antibodies in Oncology Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Antibodies in Oncology Market Share by Region (2018-2023)
Table 10. Global Antibodies in Oncology Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Antibodies in Oncology Market Share by Region (2024-2033)
Table 12. Antibodies in Oncology Market Trends
Table 13. Antibodies in Oncology Market Drivers
Table 14. Antibodies in Oncology Market Challenges
Table 15. Antibodies in Oncology Market Restraints
Table 16. Global Antibodies in Oncology Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Antibodies in Oncology Market Share by Players (2018-2023)
Table 18. Global Top Antibodies in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibodies in Oncology as of 2022)
Table 19. Ranking of Global Top Antibodies in Oncology Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Antibodies in Oncology Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Antibodies in Oncology Product Solution and Service
Table 23. Date of Enter into Antibodies in Oncology Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Antibodies in Oncology Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Antibodies in Oncology Revenue Market Share by Type (2018-2023)
Table 27. Global Antibodies in Oncology Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Antibodies in Oncology Revenue Market Share by Type (2024-2033)
Table 29. Global Antibodies in Oncology Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Antibodies in Oncology Revenue Market Share by Application (2018-2023)
Table 31. Global Antibodies in Oncology Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Antibodies in Oncology Revenue Market Share by Application (2024-2033)
Table 33. North America Antibodies in Oncology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Antibodies in Oncology Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Antibodies in Oncology Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Antibodies in Oncology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Antibodies in Oncology Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Antibodies in Oncology Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Antibodies in Oncology Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Antibodies in Oncology Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Antibodies in Oncology Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Antibodies in Oncology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Antibodies in Oncology Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Antibodies in Oncology Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Antibodies in Oncology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Antibodies in Oncology Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Antibodies in Oncology Market Size by Country (2024-2033) & (US$ Million)
Table 48. Novartis International AG Company Detail
Table 49. Novartis International AG Business Overview
Table 50. Novartis International AG Antibodies in Oncology Product
Table 51. Novartis International AG Revenue in Antibodies in Oncology Business (2018-2023) & (US$ Million)
Table 52. Novartis International AG Recent Development
Table 53. GlaxoSmithKline plc Company Detail
Table 54. GlaxoSmithKline plc Business Overview
Table 55. GlaxoSmithKline plc Antibodies in Oncology Product
Table 56. GlaxoSmithKline plc Revenue in Antibodies in Oncology Business (2018-2023) & (US$ Million)
Table 57. GlaxoSmithKline plc Recent Development
Table 58. Biogen Idec Inc. Company Detail
Table 59. Biogen Idec Inc. Business Overview
Table 60. Biogen Idec Inc. Antibodies in Oncology Product
Table 61. Biogen Idec Inc. Revenue in Antibodies in Oncology Business (2018-2023) & (US$ Million)
Table 62. Biogen Idec Inc. Recent Development
Table 63. Bristol Myers Squibb Co. Company Detail
Table 64. Bristol Myers Squibb Co. Business Overview
Table 65. Bristol Myers Squibb Co. Antibodies in Oncology Product
Table 66. Bristol Myers Squibb Co. Revenue in Antibodies in Oncology Business (2018-2023) & (US$ Million)
Table 67. Bristol Myers Squibb Co. Recent Development
Table 68. AstraZeneca plc. Company Detail
Table 69. AstraZeneca plc. Business Overview
Table 70. AstraZeneca plc. Antibodies in Oncology Product
Table 71. AstraZeneca plc. Revenue in Antibodies in Oncology Business (2018-2023) & (US$ Million)
Table 72. AstraZeneca plc. Recent Development
Table 73. Celltrion Company Detail
Table 74. Celltrion Business Overview
Table 75. Celltrion Antibodies in Oncology Product
Table 76. Celltrion Revenue in Antibodies in Oncology Business (2018-2023) & (US$ Million)
Table 77. Celltrion Recent Development
Table 78. 3SBIO Company Detail
Table 79. 3SBIO Business Overview
Table 80. 3SBIO Antibodies in Oncology Product
Table 81. 3SBIO Revenue in Antibodies in Oncology Business (2018-2023) & (US$ Million)
Table 82. 3SBIO Recent Development
Table 83. Celgen Biopharma Company Detail
Table 84. Celgen Biopharma Business Overview
Table 85. Celgen Biopharma Antibodies in Oncology Product
Table 86. Celgen Biopharma Revenue in Antibodies in Oncology Business (2018-2023) & (US$ Million)
Table 87. Celgen Biopharma Recent Development
Table 88. Dr Reddy’s Company Detail
Table 89. Dr Reddy’s Business Overview
Table 90. Dr Reddy’s Antibodies in Oncology Product
Table 91. Dr Reddy’s Revenue in Antibodies in Oncology Business (2018-2023) & (US$ Million)
Table 92. Dr Reddy’s Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antibodies in Oncology Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Antibodies in Oncology Market Share by Type: 2022 VS 2033
Figure 3. Murine Antibodies Features
Figure 4. Chimeric and Humanised Antibodies Features
Figure 5. Fully Humanized Antibodies Features
Figure 6. Others Features
Figure 7. Global Antibodies in Oncology Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Antibodies in Oncology Market Share by Application: 2022 VS 2033
Figure 9. Hospitals Case Studies
Figure 10. Academic Institutes Case Studies
Figure 11. Clinics Case Studies
Figure 12. Antibodies in Oncology Report Years Considered
Figure 13. Global Antibodies in Oncology Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Antibodies in Oncology Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Antibodies in Oncology Market Share by Region: 2022 VS 2033
Figure 16. Global Antibodies in Oncology Market Share by Players in 2022
Figure 17. Global Top Antibodies in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibodies in Oncology as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Antibodies in Oncology Revenue in 2022
Figure 19. North America Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Antibodies in Oncology Market Share by Country (2018-2033)
Figure 21. United States Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Antibodies in Oncology Market Share by Country (2018-2033)
Figure 25. Germany Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Antibodies in Oncology Market Share by Region (2018-2033)
Figure 33. China Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Antibodies in Oncology Market Share by Country (2018-2033)
Figure 41. Mexico Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Antibodies in Oncology Market Share by Country (2018-2033)
Figure 45. Turkey Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Antibodies in Oncology Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Novartis International AG Revenue Growth Rate in Antibodies in Oncology Business (2018-2023)
Figure 48. GlaxoSmithKline plc Revenue Growth Rate in Antibodies in Oncology Business (2018-2023)
Figure 49. Biogen Idec Inc. Revenue Growth Rate in Antibodies in Oncology Business (2018-2023)
Figure 50. Bristol Myers Squibb Co. Revenue Growth Rate in Antibodies in Oncology Business (2018-2023)
Figure 51. AstraZeneca plc. Revenue Growth Rate in Antibodies in Oncology Business (2018-2023)
Figure 52. Celltrion Revenue Growth Rate in Antibodies in Oncology Business (2018-2023)
Figure 53. 3SBIO Revenue Growth Rate in Antibodies in Oncology Business (2018-2023)
Figure 54. Celgen Biopharma Revenue Growth Rate in Antibodies in Oncology Business (2018-2023)
Figure 55. Dr Reddy’s Revenue Growth Rate in Antibodies in Oncology Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed